Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) Interest Paid (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Interest Paid of $54,517 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$30,006 a year earlier and up 100.7% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Interest Paid (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Elite Pharmaceuticals' Interest Paid came in at $198,885, down 54.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $246,118, down 63.4% from FY2025.

  • Interest Paid has a five-year compound annual growth rate of 6.9% (FY2021 to FY2026).
  • By fiscal year, Interest Paid came in at $672,409 in FY2025 (+463.1%), $119,412 in FY2024 (-89.1%), $1.1 million in FY2023 (+518.4%) and $177,636 in FY2022 (+0.8%).
  • Five-year quarterly Interest Paid spans a low of -$30,006 in fiscal Q2 2026 and a high of $322,681 in fiscal Q3 2023.
  • The high point for year-over-year Interest Paid in five years was fiscal Q3 2023 (growth of 762.8%); the low point was fiscal Q1 2027 (a decline of 82.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $27,170 (Q1 2027), $89,727 (Q4 2026) and $27,471 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -1.78 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 283.00 Mn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 54,517.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 54,517.00
Jun 30, 2026 27,170.00
Mar 31, 2026 89,727.00
Dec 31, 2025 27,471.00
Sep 30, 2025 -30,006.00
Jun 30, 2025 158,926.00
Mar 31, 2025 168,816.00
Dec 31, 2024 136,458.00
Sep 30, 2024 144,165.00
Jun 30, 2024 222,970.00
Jun 30, 2023 119,412.00
Mar 31, 2023 316,316.00
Dec 31, 2022 322,681.00
Sep 30, 2022 242,753.00
Jun 30, 2022 216,787.00
Mar 31, 2022 51,260.00
Dec 31, 2021 37,400.00
Sep 30, 2021 74,933.00
Jun 30, 2021 14,043.00
Mar 31, 2021 -63,761.00
API Access

Elite Pharmaceuticals Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=ELTP&period=max&api_key=YOUR_API_KEY